Page 1

ANTERIS ASX ANNOUNCEMENT QUARTERLY ACTIVITY REPORT FOR THE PERIOD TO 30 JUNE 2021 Anteris Technologies Ltd ( ASX : AVR ) ( Anteris or " the Company " ) releases its Appendix 4C - Quarterly Cash Flow report and commentary for the quarter ended 30 June 2021 ( Q2 , 2021 ) . Highlights • • • • • • Concept lock on critical components of the ComASUR ™ Transfemoral Delivery System . Proof of Concept ( POC ) animal study on the viability of ADAPTⓇ treated conduits in the carotid artery showed no calcification . FDA Early Feasibility Study submission progressed . Anteris selected to present DurAVR ™ at leading Innovation session at Transcatheter Valve Therapies ( TVT ) Structural Heart Summit 2021 , July 20-22 . $ 1.49M R & D tax refund received . An expanded funding package with Mercer Street Global Opportunity Fund , LLC ( Mercer ) realizing $ 4.1M . A further $ 2.3M capital raise to institutional investors . • Revenue of $ 1.6M mostly from LeMaitre Vascular , Inc. COMMENTARY ON THE QUARTER During the quarter , Anteris ' position as a serious player in the TAVR market in the not - distant future was cemented with the successful in vivo demonstration of its ComASUR ™ Transfemoral Delivery System . ComASUR ™ enables a surgeon to deliver its clinically superior DurAVR ™ valve accurately and consistently into the same position as the native valve ( i.e. , commissural alignment ) , an important feature not available with existing marketed products . It provides superior hemodynamics leading to better patient outcomes . In June 2021 , Anteris reported on its Proof of Concept ( POC ) animal study testing the viability of ADAPTⓇ treated conduits in the carotid artery . The conduits treated with Anteris ' ADAPT®Ⓡ tissue technology showed no evidence of calcification , a major step towards ADAPTⓇ treated prosthetic conduits for use in CABG ( coronary artery bypass graft ) surgeries . Anteris plans to start a larger animal study in Australia during 2021 , implanting the conduit into the CABG position . Anteris Technologies Ltd Registered Office : Toowong Tower , Suite 302 , Level 3 , 9 Sherwood Rd , Toowong , Queensland , 4066 Customer Service T +61 1300 550 310 | F +61 1300 972 437 | E info@anteristech.com | W anteristech.com Brisbane ▪ Minneapolis ▪Geneva ▪ Malaga ADAPT for life